Danaher Other developed markets — Sales increased by 15.2% to $364.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.4%, from $359.00M to $364.00M. Over 3 years (FY 2022 to FY 2025), Other developed markets — Sales shows relatively stable performance with a -2.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration or growing demand in these specific developed economies, while a decrease may signal competitive pressure or economic headwinds in those regions.
This metric represents the total revenue generated from sales of products and services within developed geographic regio...
Peers in the life sciences and diagnostics sectors typically report this as part of their international revenue breakdown, often comparing it against emerging market performance to gauge global footprint maturity.
dhr_segment_other_developed_markets_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $336.25M | $336.25M | $336.25M | $336.25M | $317.50M | $317.50M | $317.50M | $317.50M | $303.00M | $292.00M | $299.00M | $359.00M | $278.00M | $294.00M | $316.00M | $364.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -5.6% | +0.0% | +0.0% | +0.0% | -4.6% | -3.6% | +2.4% | +20.1% | -22.6% | +5.8% | +7.5% | +15.2% |
| YoY Change | — | — | — | — | -5.6% | -5.6% | -5.6% | -5.6% | -4.6% | -8.0% | -5.8% | +13.1% | -8.3% | +0.7% | +5.7% | +1.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.